US Stock MarketDetailed Quotes
SNOA Sonoma Pharmaceuticals
- 0.2786
- +0.0438+18.65%
Close Jul 3 13:00 ET
- 0.2661
- -0.0125-4.49%
Post 16:57 ET
5.29MMarket Cap-525P/E (TTM)
0.3314High0.2299Low10.48MVolume0.2400Open0.2348Pre Close2.94MTurnover56.40%Turnover RatioLossP/E (Static)19.00MShares1.190052wk High0.86P/B5.17MFloat Cap0.115952wk Low--Dividend TTM18.57MShs Float3616.1593Historical High--Div YieldTTM43.23%Amplitude0.1159Historical Low0.2800Avg Price1Lot Size
Sonoma Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 61.02%-2.4M | 106.23%152K | -217.24%-1.1M | 32.73%-1.23M | 85.98%-215K | -44.82%-6.15M | -74.98%-2.44M | -6.75%-348K | -40.34%-1.83M | -25.35%-1.53M |
| Net income from continuing operations | 6.13%-4.84M | 18.43%-1.07M | 55.34%-866K | -45.92%-1.48M | -59.86%-1.42M | -1.28%-5.15M | 55.57%-1.31M | -105.40%-1.94M | -917.00%-1.02M | 19.22%-887K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 99.86%-1K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 40.80%176K | 20.59%41K | 40.63%45K | 60.71%45K | 45.16%45K | -32.80%125K | -30.61%34K | -13.51%32K | -46.15%28K | -35.42%31K |
| Deferred tax | -194.59%-109K | -197.10%-201K | ---- | ---- | 325.00%90K | 95.54%-37K | --207K | ---- | ---- | ---40K |
| Other non cash items | -6.94%161K | ---- | ---- | ---- | ---- | -22.42%173K | ---- | ---- | ---- | ---- |
| Change In working capital | 187.72%1.69M | 169.81%1.15M | -132.99%-515K | 116.90%168K | 204.70%891K | -161.64%-1.93M | -150.24%-1.65M | 131.26%1.56M | -69.05%-994K | -266.81%-851K |
| -Change in receivables | -5,650.00%-230K | 93.23%-9K | -306.23%-596K | 311.49%184K | 361.64%191K | -100.20%-4K | -106.55%-133K | -46.18%289K | 81.99%-87K | 34.82%-73K |
| -Change in inventory | --184K | 70.99%277K | -274.04%-496K | 163.60%173K | 231.43%230K | --0 | -39.10%162K | 166.90%285K | -494.20%-272K | -1,844.44%-175K |
| -Change in prepaid assets | 461.76%1.11M | 163.90%561K | 185.14%499K | -72.30%131K | -10.53%-84K | 33.48%-306K | -52.96%-878K | -55.92%175K | 785.51%473K | 64.49%-76K |
| -Change in payables and accrued expense | 163.34%216K | 116.53%98K | -85.13%101K | 52.88%-499K | -18.35%516K | -138.66%-341K | -189.71%-593K | 534.58%679K | -2,202.17%-1.06M | 295.00%632K |
| -Change in other current assets | ---- | ---- | -72.60%20K | --0 | 154.84%79K | ---- | ---- | 1.39%73K | -211.11%-10K | -53.73%31K |
| -Change in other current liabilities | 6.94%-161K | 21.52%-62K | 71.83%-20K | --0 | 15.96%-79K | 22.07%-173K | -2.60%-79K | 0.00%-71K | 987.50%71K | -42.42%-94K |
| -Change in other working capital | 152.17%577K | 1,335.48%383K | -117.56%-23K | 262.73%179K | 103.47%38K | -204.34%-1.11M | -102.77%-31K | 122.03%131K | -83.33%-110K | -1,789.66%-1.1M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 61.02%-2.4M | 106.23%152K | -217.24%-1.1M | 32.73%-1.23M | 85.98%-215K | -44.82%-6.15M | -74.98%-2.44M | -6.75%-348K | -40.34%-1.83M | -25.35%-1.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 99.22%-2K | 121.95%18K | -102.94%-1K | 98.93%-2K | 26.09%-17K | -160.61%-258K | -34.43%-82K | 34K | -1,800.00%-187K | 53.06%-23K |
| Net PPE purchase and sale | 93.68%-17K | 101.58%3K | 96.77%-1K | 92.00%-2K | 26.09%-17K | -96.35%-269K | -206.45%-190K | -3,000.00%-31K | 0.00%-25K | 53.06%-23K |
| Net other investing changes | 36.36%15K | ---- | ---- | ---- | ---- | -71.05%11K | 10,700.00%108K | 6,400.00%65K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 99.22%-2K | 121.95%18K | -102.94%-1K | 98.93%-2K | 26.09%-17K | -160.61%-258K | -34.43%-82K | --34K | -1,800.00%-187K | 53.06%-23K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -32.66%1.68M | -81.55%622K | 514.47%1.32M | 27.53%-129K | 65.12%-135K | -66.35%2.49M | 1,418.92%3.37M | -168.68%-318K | -102.57%-178K | -85.17%-387K |
| Net issuance payments of debt | 46.20%-481K | 6.00%-94K | 44.10%-128K | 40.00%-129K | 62.86%-130K | -139.04%-894K | -145.05%-100K | -15.08%-229K | -8.59%-215K | -75.88%-350K |
| Net common stock issuance | -37.80%1.78M | -88.21%338K | --1.45M | --0 | ---5K | -62.03%2.87M | --2.87M | --0 | --0 | --0 |
| Net other financing activities | -27.57%373K | -37.42%378K | ---- | ---- | ---- | --515K | --604K | ---- | ---- | ---37K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -32.66%1.68M | -81.55%622K | 514.47%1.32M | 27.53%-129K | 65.12%-135K | -66.35%2.49M | 1,418.92%3.37M | -168.68%-318K | -102.57%-178K | -85.17%-387K |
| Net cash flow | ||||||||||
| Beginning cash position | -48.35%3.82M | -8.66%2.41M | -36.23%2.14M | -36.56%3.54M | -48.35%3.82M | 75.26%7.4M | -69.12%2.63M | -60.07%3.35M | 98.72%5.59M | 75.26%7.4M |
| Current changes in cash | 81.54%-724K | -6.71%792K | 133.70%213K | 37.95%-1.36M | 81.11%-367K | -228.60%-3.92M | 168.80%849K | -561.31%-632K | -139.01%-2.2M | -31.20%-1.94M |
| Effect of exchange rate changes | -90.72%32K | -120.77%-70K | 165.88%56K | -12.50%-45K | -31.58%91K | 171.65%345K | 233.66%337K | ---85K | 13.04%-40K | 84.72%133K |
| End cash Position | -18.12%3.13M | -18.12%3.13M | -8.66%2.41M | -36.23%2.14M | -36.56%3.54M | -48.35%3.82M | -48.35%3.82M | -69.12%2.63M | -60.07%3.35M | 98.72%5.59M |
| Free cash flow | 62.39%-2.42M | 105.89%155K | -191.56%-1.11M | 33.53%-1.23M | 85.09%-232K | -46.43%-6.42M | -80.58%-2.63M | -15.90%-379K | -39.58%-1.86M | -22.33%-1.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
